Global Cancer Tumor Profiling Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 136
Published Date: 02 Jan 2024
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Cancer Tumor Profiling market size was valued at USD 40550 million in 2023 and is forecast to a readjusted size of USD 78790 million by 2030 with a CAGR of 10.0% during review period.
Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid “over-treatment” of the cancer patients.
The global market is driven by growing demand for cancer profiling method by oncologists to diagnose or treat cancers as well as predict response to targeted therapy. In addition, rise in adoption of cancer biomarkers for tumor profiling, increase in incidence of cancer across the globe, and growth in use of next-generation sequencing technique for cancer profiling boost the market growth. However, high monetary investments for the development of biomarkers and dearth of skilled professionals or oncologists specific to tumor profiling hamper the market growth.
The Global Info Research report includes an overview of the development of the Cancer Tumor Profiling industry chain, the market status of Personalized Medicine (Next-generation Sequencing (NGS), Polymerase Chain Reaction (PCR)), Diagnostics (Next-generation Sequencing (NGS), Polymerase Chain Reaction (PCR)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cancer Tumor Profiling.
Regionally, the report analyzes the Cancer Tumor Profiling markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cancer Tumor Profiling market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cancer Tumor Profiling market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cancer Tumor Profiling industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Next-generation Sequencing (NGS), Polymerase Chain Reaction (PCR)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cancer Tumor Profiling market.
Regional Analysis: The report involves examining the Cancer Tumor Profiling market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cancer Tumor Profiling market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cancer Tumor Profiling:
Company Analysis: Report covers individual Cancer Tumor Profiling players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cancer Tumor Profiling This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Personalized Medicine, Diagnostics).
Technology Analysis: Report covers specific technologies relevant to Cancer Tumor Profiling. It assesses the current state, advancements, and potential future developments in Cancer Tumor Profiling areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cancer Tumor Profiling market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cancer Tumor Profiling market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Next-generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Microarray
Others
Market segment by Application
Personalized Medicine
Diagnostics
Biomarker Discovery
Prognostics
Research Applications
Market segment by players, this report covers
Qiagen N.V.
Roche Molecular Systems Inc.
Abott Molecular
Illumina Inc.
NeoGenomics Laboratories
HTG Molecular Diagnostic
Genomic Health Inc.
Hologic Gen-Probe
BD Biosciences
Siemens Healthineers
Claris Life Sciences
Personal Genome Diagnostics, Inc.
Perthera, Inc.
Foundation Medicine, Inc
V., Strand
ApoCell
Contextual Genomics
Agendia
GenScript
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cancer Tumor Profiling product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cancer Tumor Profiling, with revenue, gross margin and global market share of Cancer Tumor Profiling from 2019 to 2024.
Chapter 3, the Cancer Tumor Profiling competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cancer Tumor Profiling market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Tumor Profiling.
Chapter 13, to describe Cancer Tumor Profiling research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Cancer Tumor Profiling
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cancer Tumor Profiling by Type
1.3.1 Overview: Global Cancer Tumor Profiling Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Cancer Tumor Profiling Consumption Value Market Share by Type in 2023
1.3.3 Next-generation Sequencing (NGS)
1.3.4 Polymerase Chain Reaction (PCR)
1.3.5 Immunohistochemistry (IHC)
1.3.6 In Situ Hybridization (ISH)
1.3.7 Microarray
1.3.8 Others
1.4 Global Cancer Tumor Profiling Market by Application
1.4.1 Overview: Global Cancer Tumor Profiling Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Personalized Medicine
1.4.3 Diagnostics
1.4.4 Biomarker Discovery
1.4.5 Prognostics
1.4.6 Research Applications
1.5 Global Cancer Tumor Profiling Market Size & Forecast
1.6 Global Cancer Tumor Profiling Market Size and Forecast by Region
1.6.1 Global Cancer Tumor Profiling Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Cancer Tumor Profiling Market Size by Region, (2019-2030)
1.6.3 North America Cancer Tumor Profiling Market Size and Prospect (2019-2030)
1.6.4 Europe Cancer Tumor Profiling Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Cancer Tumor Profiling Market Size and Prospect (2019-2030)
1.6.6 South America Cancer Tumor Profiling Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Cancer Tumor Profiling Market Size and Prospect (2019-2030)
2.1 Qiagen N.V.
2.1.1 Qiagen N.V. Details
2.1.2 Qiagen N.V. Major Business
2.1.3 Qiagen N.V. Cancer Tumor Profiling Product and Solutions
2.1.4 Qiagen N.V. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Qiagen N.V. Recent Developments and Future Plans
2.2 Roche Molecular Systems Inc.
2.2.1 Roche Molecular Systems Inc. Details
2.2.2 Roche Molecular Systems Inc. Major Business
2.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Product and Solutions
2.2.4 Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche Molecular Systems Inc. Recent Developments and Future Plans
2.3 Abott Molecular
2.3.1 Abott Molecular Details
2.3.2 Abott Molecular Major Business
2.3.3 Abott Molecular Cancer Tumor Profiling Product and Solutions
2.3.4 Abott Molecular Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Abott Molecular Recent Developments and Future Plans
2.4 Illumina Inc.
2.4.1 Illumina Inc. Details
2.4.2 Illumina Inc. Major Business
2.4.3 Illumina Inc. Cancer Tumor Profiling Product and Solutions
2.4.4 Illumina Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Illumina Inc. Recent Developments and Future Plans
2.5 NeoGenomics Laboratories
2.5.1 NeoGenomics Laboratories Details
2.5.2 NeoGenomics Laboratories Major Business
2.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Product and Solutions
2.5.4 NeoGenomics Laboratories Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 NeoGenomics Laboratories Recent Developments and Future Plans
2.6 HTG Molecular Diagnostic
2.6.1 HTG Molecular Diagnostic Details
2.6.2 HTG Molecular Diagnostic Major Business
2.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Product and Solutions
2.6.4 HTG Molecular Diagnostic Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 HTG Molecular Diagnostic Recent Developments and Future Plans
2.7 Genomic Health Inc.
2.7.1 Genomic Health Inc. Details
2.7.2 Genomic Health Inc. Major Business
2.7.3 Genomic Health Inc. Cancer Tumor Profiling Product and Solutions
2.7.4 Genomic Health Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Genomic Health Inc. Recent Developments and Future Plans
2.8 Hologic Gen-Probe
2.8.1 Hologic Gen-Probe Details
2.8.2 Hologic Gen-Probe Major Business
2.8.3 Hologic Gen-Probe Cancer Tumor Profiling Product and Solutions
2.8.4 Hologic Gen-Probe Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Hologic Gen-Probe Recent Developments and Future Plans
2.9 BD Biosciences
2.9.1 BD Biosciences Details
2.9.2 BD Biosciences Major Business
2.9.3 BD Biosciences Cancer Tumor Profiling Product and Solutions
2.9.4 BD Biosciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 BD Biosciences Recent Developments and Future Plans
2.10 Siemens Healthineers
2.10.1 Siemens Healthineers Details
2.10.2 Siemens Healthineers Major Business
2.10.3 Siemens Healthineers Cancer Tumor Profiling Product and Solutions
2.10.4 Siemens Healthineers Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Siemens Healthineers Recent Developments and Future Plans
2.11 Claris Life Sciences
2.11.1 Claris Life Sciences Details
2.11.2 Claris Life Sciences Major Business
2.11.3 Claris Life Sciences Cancer Tumor Profiling Product and Solutions
2.11.4 Claris Life Sciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Claris Life Sciences Recent Developments and Future Plans
2.12 Personal Genome Diagnostics, Inc.
2.12.1 Personal Genome Diagnostics, Inc. Details
2.12.2 Personal Genome Diagnostics, Inc. Major Business
2.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product and Solutions
2.12.4 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Personal Genome Diagnostics, Inc. Recent Developments and Future Plans
2.13 Perthera, Inc.
2.13.1 Perthera, Inc. Details
2.13.2 Perthera, Inc. Major Business
2.13.3 Perthera, Inc. Cancer Tumor Profiling Product and Solutions
2.13.4 Perthera, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Perthera, Inc. Recent Developments and Future Plans
2.14 Foundation Medicine, Inc
2.14.1 Foundation Medicine, Inc Details
2.14.2 Foundation Medicine, Inc Major Business
2.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Product and Solutions
2.14.4 Foundation Medicine, Inc Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Foundation Medicine, Inc Recent Developments and Future Plans
2.15 V., Strand
2.15.1 V., Strand Details
2.15.2 V., Strand Major Business
2.15.3 V., Strand Cancer Tumor Profiling Product and Solutions
2.15.4 V., Strand Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 V., Strand Recent Developments and Future Plans
2.16 ApoCell
2.16.1 ApoCell Details
2.16.2 ApoCell Major Business
2.16.3 ApoCell Cancer Tumor Profiling Product and Solutions
2.16.4 ApoCell Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 ApoCell Recent Developments and Future Plans
2.17 Contextual Genomics
2.17.1 Contextual Genomics Details
2.17.2 Contextual Genomics Major Business
2.17.3 Contextual Genomics Cancer Tumor Profiling Product and Solutions
2.17.4 Contextual Genomics Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Contextual Genomics Recent Developments and Future Plans
2.18 Agendia
2.18.1 Agendia Details
2.18.2 Agendia Major Business
2.18.3 Agendia Cancer Tumor Profiling Product and Solutions
2.18.4 Agendia Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Agendia Recent Developments and Future Plans
2.19 GenScript
2.19.1 GenScript Details
2.19.2 GenScript Major Business
2.19.3 GenScript Cancer Tumor Profiling Product and Solutions
2.19.4 GenScript Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 GenScript Recent Developments and Future Plans
3.1 Global Cancer Tumor Profiling Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Cancer Tumor Profiling by Company Revenue
3.2.2 Top 3 Cancer Tumor Profiling Players Market Share in 2023
3.2.3 Top 6 Cancer Tumor Profiling Players Market Share in 2023
3.3 Cancer Tumor Profiling Market: Overall Company Footprint Analysis
3.3.1 Cancer Tumor Profiling Market: Region Footprint
3.3.2 Cancer Tumor Profiling Market: Company Product Type Footprint
3.3.3 Cancer Tumor Profiling Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Cancer Tumor Profiling Consumption Value and Market Share by Type (2019-2024)
4.2 Global Cancer Tumor Profiling Market Forecast by Type (2025-2030)
5.1 Global Cancer Tumor Profiling Consumption Value Market Share by Application (2019-2024)
5.2 Global Cancer Tumor Profiling Market Forecast by Application (2025-2030)
6.1 North America Cancer Tumor Profiling Consumption Value by Type (2019-2030)
6.2 North America Cancer Tumor Profiling Consumption Value by Application (2019-2030)
6.3 North America Cancer Tumor Profiling Market Size by Country
6.3.1 North America Cancer Tumor Profiling Consumption Value by Country (2019-2030)
6.3.2 United States Cancer Tumor Profiling Market Size and Forecast (2019-2030)
6.3.3 Canada Cancer Tumor Profiling Market Size and Forecast (2019-2030)
6.3.4 Mexico Cancer Tumor Profiling Market Size and Forecast (2019-2030)
7.1 Europe Cancer Tumor Profiling Consumption Value by Type (2019-2030)
7.2 Europe Cancer Tumor Profiling Consumption Value by Application (2019-2030)
7.3 Europe Cancer Tumor Profiling Market Size by Country
7.3.1 Europe Cancer Tumor Profiling Consumption Value by Country (2019-2030)
7.3.2 Germany Cancer Tumor Profiling Market Size and Forecast (2019-2030)
7.3.3 France Cancer Tumor Profiling Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Cancer Tumor Profiling Market Size and Forecast (2019-2030)
7.3.5 Russia Cancer Tumor Profiling Market Size and Forecast (2019-2030)
7.3.6 Italy Cancer Tumor Profiling Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Cancer Tumor Profiling Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Cancer Tumor Profiling Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Cancer Tumor Profiling Market Size by Region
8.3.1 Asia-Pacific Cancer Tumor Profiling Consumption Value by Region (2019-2030)
8.3.2 China Cancer Tumor Profiling Market Size and Forecast (2019-2030)
8.3.3 Japan Cancer Tumor Profiling Market Size and Forecast (2019-2030)
8.3.4 South Korea Cancer Tumor Profiling Market Size and Forecast (2019-2030)
8.3.5 India Cancer Tumor Profiling Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Cancer Tumor Profiling Market Size and Forecast (2019-2030)
8.3.7 Australia Cancer Tumor Profiling Market Size and Forecast (2019-2030)
9.1 South America Cancer Tumor Profiling Consumption Value by Type (2019-2030)
9.2 South America Cancer Tumor Profiling Consumption Value by Application (2019-2030)
9.3 South America Cancer Tumor Profiling Market Size by Country
9.3.1 South America Cancer Tumor Profiling Consumption Value by Country (2019-2030)
9.3.2 Brazil Cancer Tumor Profiling Market Size and Forecast (2019-2030)
9.3.3 Argentina Cancer Tumor Profiling Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Cancer Tumor Profiling Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Cancer Tumor Profiling Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Cancer Tumor Profiling Market Size by Country
10.3.1 Middle East & Africa Cancer Tumor Profiling Consumption Value by Country (2019-2030)
10.3.2 Turkey Cancer Tumor Profiling Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Cancer Tumor Profiling Market Size and Forecast (2019-2030)
10.3.4 UAE Cancer Tumor Profiling Market Size and Forecast (2019-2030)
11.1 Cancer Tumor Profiling Market Drivers
11.2 Cancer Tumor Profiling Market Restraints
11.3 Cancer Tumor Profiling Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Cancer Tumor Profiling Industry Chain
12.2 Cancer Tumor Profiling Upstream Analysis
12.3 Cancer Tumor Profiling Midstream Analysis
12.4 Cancer Tumor Profiling Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Cancer Tumor Profiling Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Cancer Tumor Profiling Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Cancer Tumor Profiling Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Cancer Tumor Profiling Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Qiagen N.V. Company Information, Head Office, and Major Competitors
Table 6. Qiagen N.V. Major Business
Table 7. Qiagen N.V. Cancer Tumor Profiling Product and Solutions
Table 8. Qiagen N.V. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Qiagen N.V. Recent Developments and Future Plans
Table 10. Roche Molecular Systems Inc. Company Information, Head Office, and Major Competitors
Table 11. Roche Molecular Systems Inc. Major Business
Table 12. Roche Molecular Systems Inc. Cancer Tumor Profiling Product and Solutions
Table 13. Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Roche Molecular Systems Inc. Recent Developments and Future Plans
Table 15. Abott Molecular Company Information, Head Office, and Major Competitors
Table 16. Abott Molecular Major Business
Table 17. Abott Molecular Cancer Tumor Profiling Product and Solutions
Table 18. Abott Molecular Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Abott Molecular Recent Developments and Future Plans
Table 20. Illumina Inc. Company Information, Head Office, and Major Competitors
Table 21. Illumina Inc. Major Business
Table 22. Illumina Inc. Cancer Tumor Profiling Product and Solutions
Table 23. Illumina Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Illumina Inc. Recent Developments and Future Plans
Table 25. NeoGenomics Laboratories Company Information, Head Office, and Major Competitors
Table 26. NeoGenomics Laboratories Major Business
Table 27. NeoGenomics Laboratories Cancer Tumor Profiling Product and Solutions
Table 28. NeoGenomics Laboratories Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. NeoGenomics Laboratories Recent Developments and Future Plans
Table 30. HTG Molecular Diagnostic Company Information, Head Office, and Major Competitors
Table 31. HTG Molecular Diagnostic Major Business
Table 32. HTG Molecular Diagnostic Cancer Tumor Profiling Product and Solutions
Table 33. HTG Molecular Diagnostic Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. HTG Molecular Diagnostic Recent Developments and Future Plans
Table 35. Genomic Health Inc. Company Information, Head Office, and Major Competitors
Table 36. Genomic Health Inc. Major Business
Table 37. Genomic Health Inc. Cancer Tumor Profiling Product and Solutions
Table 38. Genomic Health Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Genomic Health Inc. Recent Developments and Future Plans
Table 40. Hologic Gen-Probe Company Information, Head Office, and Major Competitors
Table 41. Hologic Gen-Probe Major Business
Table 42. Hologic Gen-Probe Cancer Tumor Profiling Product and Solutions
Table 43. Hologic Gen-Probe Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Hologic Gen-Probe Recent Developments and Future Plans
Table 45. BD Biosciences Company Information, Head Office, and Major Competitors
Table 46. BD Biosciences Major Business
Table 47. BD Biosciences Cancer Tumor Profiling Product and Solutions
Table 48. BD Biosciences Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. BD Biosciences Recent Developments and Future Plans
Table 50. Siemens Healthineers Company Information, Head Office, and Major Competitors
Table 51. Siemens Healthineers Major Business
Table 52. Siemens Healthineers Cancer Tumor Profiling Product and Solutions
Table 53. Siemens Healthineers Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Siemens Healthineers Recent Developments and Future Plans
Table 55. Claris Life Sciences Company Information, Head Office, and Major Competitors
Table 56. Claris Life Sciences Major Business
Table 57. Claris Life Sciences Cancer Tumor Profiling Product and Solutions
Table 58. Claris Life Sciences Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Claris Life Sciences Recent Developments and Future Plans
Table 60. Personal Genome Diagnostics, Inc. Company Information, Head Office, and Major Competitors
Table 61. Personal Genome Diagnostics, Inc. Major Business
Table 62. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product and Solutions
Table 63. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Personal Genome Diagnostics, Inc. Recent Developments and Future Plans
Table 65. Perthera, Inc. Company Information, Head Office, and Major Competitors
Table 66. Perthera, Inc. Major Business
Table 67. Perthera, Inc. Cancer Tumor Profiling Product and Solutions
Table 68. Perthera, Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Perthera, Inc. Recent Developments and Future Plans
Table 70. Foundation Medicine, Inc Company Information, Head Office, and Major Competitors
Table 71. Foundation Medicine, Inc Major Business
Table 72. Foundation Medicine, Inc Cancer Tumor Profiling Product and Solutions
Table 73. Foundation Medicine, Inc Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Foundation Medicine, Inc Recent Developments and Future Plans
Table 75. V., Strand Company Information, Head Office, and Major Competitors
Table 76. V., Strand Major Business
Table 77. V., Strand Cancer Tumor Profiling Product and Solutions
Table 78. V., Strand Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. V., Strand Recent Developments and Future Plans
Table 80. ApoCell Company Information, Head Office, and Major Competitors
Table 81. ApoCell Major Business
Table 82. ApoCell Cancer Tumor Profiling Product and Solutions
Table 83. ApoCell Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. ApoCell Recent Developments and Future Plans
Table 85. Contextual Genomics Company Information, Head Office, and Major Competitors
Table 86. Contextual Genomics Major Business
Table 87. Contextual Genomics Cancer Tumor Profiling Product and Solutions
Table 88. Contextual Genomics Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Contextual Genomics Recent Developments and Future Plans
Table 90. Agendia Company Information, Head Office, and Major Competitors
Table 91. Agendia Major Business
Table 92. Agendia Cancer Tumor Profiling Product and Solutions
Table 93. Agendia Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Agendia Recent Developments and Future Plans
Table 95. GenScript Company Information, Head Office, and Major Competitors
Table 96. GenScript Major Business
Table 97. GenScript Cancer Tumor Profiling Product and Solutions
Table 98. GenScript Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. GenScript Recent Developments and Future Plans
Table 100. Global Cancer Tumor Profiling Revenue (USD Million) by Players (2019-2024)
Table 101. Global Cancer Tumor Profiling Revenue Share by Players (2019-2024)
Table 102. Breakdown of Cancer Tumor Profiling by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in Cancer Tumor Profiling, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 104. Head Office of Key Cancer Tumor Profiling Players
Table 105. Cancer Tumor Profiling Market: Company Product Type Footprint
Table 106. Cancer Tumor Profiling Market: Company Product Application Footprint
Table 107. Cancer Tumor Profiling New Market Entrants and Barriers to Market Entry
Table 108. Cancer Tumor Profiling Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global Cancer Tumor Profiling Consumption Value (USD Million) by Type (2019-2024)
Table 110. Global Cancer Tumor Profiling Consumption Value Share by Type (2019-2024)
Table 111. Global Cancer Tumor Profiling Consumption Value Forecast by Type (2025-2030)
Table 112. Global Cancer Tumor Profiling Consumption Value by Application (2019-2024)
Table 113. Global Cancer Tumor Profiling Consumption Value Forecast by Application (2025-2030)
Table 114. North America Cancer Tumor Profiling Consumption Value by Type (2019-2024) & (USD Million)
Table 115. North America Cancer Tumor Profiling Consumption Value by Type (2025-2030) & (USD Million)
Table 116. North America Cancer Tumor Profiling Consumption Value by Application (2019-2024) & (USD Million)
Table 117. North America Cancer Tumor Profiling Consumption Value by Application (2025-2030) & (USD Million)
Table 118. North America Cancer Tumor Profiling Consumption Value by Country (2019-2024) & (USD Million)
Table 119. North America Cancer Tumor Profiling Consumption Value by Country (2025-2030) & (USD Million)
Table 120. Europe Cancer Tumor Profiling Consumption Value by Type (2019-2024) & (USD Million)
Table 121. Europe Cancer Tumor Profiling Consumption Value by Type (2025-2030) & (USD Million)
Table 122. Europe Cancer Tumor Profiling Consumption Value by Application (2019-2024) & (USD Million)
Table 123. Europe Cancer Tumor Profiling Consumption Value by Application (2025-2030) & (USD Million)
Table 124. Europe Cancer Tumor Profiling Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Europe Cancer Tumor Profiling Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Asia-Pacific Cancer Tumor Profiling Consumption Value by Type (2019-2024) & (USD Million)
Table 127. Asia-Pacific Cancer Tumor Profiling Consumption Value by Type (2025-2030) & (USD Million)
Table 128. Asia-Pacific Cancer Tumor Profiling Consumption Value by Application (2019-2024) & (USD Million)
Table 129. Asia-Pacific Cancer Tumor Profiling Consumption Value by Application (2025-2030) & (USD Million)
Table 130. Asia-Pacific Cancer Tumor Profiling Consumption Value by Region (2019-2024) & (USD Million)
Table 131. Asia-Pacific Cancer Tumor Profiling Consumption Value by Region (2025-2030) & (USD Million)
Table 132. South America Cancer Tumor Profiling Consumption Value by Type (2019-2024) & (USD Million)
Table 133. South America Cancer Tumor Profiling Consumption Value by Type (2025-2030) & (USD Million)
Table 134. South America Cancer Tumor Profiling Consumption Value by Application (2019-2024) & (USD Million)
Table 135. South America Cancer Tumor Profiling Consumption Value by Application (2025-2030) & (USD Million)
Table 136. South America Cancer Tumor Profiling Consumption Value by Country (2019-2024) & (USD Million)
Table 137. South America Cancer Tumor Profiling Consumption Value by Country (2025-2030) & (USD Million)
Table 138. Middle East & Africa Cancer Tumor Profiling Consumption Value by Type (2019-2024) & (USD Million)
Table 139. Middle East & Africa Cancer Tumor Profiling Consumption Value by Type (2025-2030) & (USD Million)
Table 140. Middle East & Africa Cancer Tumor Profiling Consumption Value by Application (2019-2024) & (USD Million)
Table 141. Middle East & Africa Cancer Tumor Profiling Consumption Value by Application (2025-2030) & (USD Million)
Table 142. Middle East & Africa Cancer Tumor Profiling Consumption Value by Country (2019-2024) & (USD Million)
Table 143. Middle East & Africa Cancer Tumor Profiling Consumption Value by Country (2025-2030) & (USD Million)
Table 144. Cancer Tumor Profiling Raw Material
Table 145. Key Suppliers of Cancer Tumor Profiling Raw Materials
List of Figures
Figure 1. Cancer Tumor Profiling Picture
Figure 2. Global Cancer Tumor Profiling Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Cancer Tumor Profiling Consumption Value Market Share by Type in 2023
Figure 4. Next-generation Sequencing (NGS)
Figure 5. Polymerase Chain Reaction (PCR)
Figure 6. Immunohistochemistry (IHC)
Figure 7. In Situ Hybridization (ISH)
Figure 8. Microarray
Figure 9. Others
Figure 10. Global Cancer Tumor Profiling Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 11. Cancer Tumor Profiling Consumption Value Market Share by Application in 2023
Figure 12. Personalized Medicine Picture
Figure 13. Diagnostics Picture
Figure 14. Biomarker Discovery Picture
Figure 15. Prognostics Picture
Figure 16. Research Applications Picture
Figure 17. Global Cancer Tumor Profiling Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global Cancer Tumor Profiling Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Market Cancer Tumor Profiling Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 20. Global Cancer Tumor Profiling Consumption Value Market Share by Region (2019-2030)
Figure 21. Global Cancer Tumor Profiling Consumption Value Market Share by Region in 2023
Figure 22. North America Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East and Africa Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Cancer Tumor Profiling Revenue Share by Players in 2023
Figure 28. Cancer Tumor Profiling Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 29. Global Top 3 Players Cancer Tumor Profiling Market Share in 2023
Figure 30. Global Top 6 Players Cancer Tumor Profiling Market Share in 2023
Figure 31. Global Cancer Tumor Profiling Consumption Value Share by Type (2019-2024)
Figure 32. Global Cancer Tumor Profiling Market Share Forecast by Type (2025-2030)
Figure 33. Global Cancer Tumor Profiling Consumption Value Share by Application (2019-2024)
Figure 34. Global Cancer Tumor Profiling Market Share Forecast by Application (2025-2030)
Figure 35. North America Cancer Tumor Profiling Consumption Value Market Share by Type (2019-2030)
Figure 36. North America Cancer Tumor Profiling Consumption Value Market Share by Application (2019-2030)
Figure 37. North America Cancer Tumor Profiling Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 39. Canada Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 40. Mexico Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 41. Europe Cancer Tumor Profiling Consumption Value Market Share by Type (2019-2030)
Figure 42. Europe Cancer Tumor Profiling Consumption Value Market Share by Application (2019-2030)
Figure 43. Europe Cancer Tumor Profiling Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 45. France Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 46. United Kingdom Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 47. Russia Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 48. Italy Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Cancer Tumor Profiling Consumption Value Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Cancer Tumor Profiling Consumption Value Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Cancer Tumor Profiling Consumption Value Market Share by Region (2019-2030)
Figure 52. China Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 55. India Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 58. South America Cancer Tumor Profiling Consumption Value Market Share by Type (2019-2030)
Figure 59. South America Cancer Tumor Profiling Consumption Value Market Share by Application (2019-2030)
Figure 60. South America Cancer Tumor Profiling Consumption Value Market Share by Country (2019-2030)
Figure 61. Brazil Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 62. Argentina Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 63. Middle East and Africa Cancer Tumor Profiling Consumption Value Market Share by Type (2019-2030)
Figure 64. Middle East and Africa Cancer Tumor Profiling Consumption Value Market Share by Application (2019-2030)
Figure 65. Middle East and Africa Cancer Tumor Profiling Consumption Value Market Share by Country (2019-2030)
Figure 66. Turkey Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 67. Saudi Arabia Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 68. UAE Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
Figure 69. Cancer Tumor Profiling Market Drivers
Figure 70. Cancer Tumor Profiling Market Restraints
Figure 71. Cancer Tumor Profiling Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Manufacturing Cost Structure Analysis of Cancer Tumor Profiling in 2023
Figure 74. Manufacturing Process Analysis of Cancer Tumor Profiling
Figure 75. Cancer Tumor Profiling Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Qiagen N.V. Roche Molecular Systems Inc. Abott Molecular Illumina Inc. NeoGenomics Laboratories HTG Molecular Diagnostic Genomic Health Inc. Hologic Gen-Probe BD Biosciences Siemens Healthineers Claris Life Sciences Personal Genome Diagnostics, Inc. Perthera, Inc. Foundation Medicine, Inc V., Strand ApoCell Contextual Genomics Agendia GenScript
02 Mar 2024
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
